BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34757679)

  • 1. Acute generalized exanthematous pustulosis induced by generic hydroxychloroquine.
    Wang G; Zhuo N; Li J
    J Cosmet Dermatol; 2022 Aug; 21(8):3608-3610. PubMed ID: 34757679
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute generalized exanthematous pustulosis induced by hydroxychloroquine: a case with atypical clinical presentation.
    Duman H; Topal IO; Kocaturk E; Cure K; Mansuroglu I
    An Bras Dermatol; 2017; 92(3):404-406. PubMed ID: 29186260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxychloroquine-induced acute generalized exanthematous pustulosis with positive patch-testing.
    Charfi O; Kastalli S; Sahnoun R; Lakhoua G
    Indian J Pharmacol; 2015; 47(6):693-4. PubMed ID: 26729969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute generalized exanthematous pustulosis and Stevens-Johnson syndrome overlap due to hydroxychloroquine: a case report.
    Coleman I; Ruiz G; Brahmbhatt S; Ackerman L
    J Med Case Rep; 2020 Nov; 14(1):210. PubMed ID: 33138853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged pustular eruption from hydroxychloroquine: an unusual case of acute generalized exanthematous pustulosis.
    Pearson KC; Morrell DS; Runge SR; Jolly P
    Cutis; 2016 Mar; 97(3):212-6. PubMed ID: 27023083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The First Pediatric Case of Acute Generalized Exanthematous Pustulosis Caused by Hydroxychloroquine.
    Liccioli G; Marrani E; Giani T; Simonini G; Barni S; Mori F
    Pharmacology; 2019; 104(1-2):57-59. PubMed ID: 31067554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporine for corticosteroid-refractory acute generalized exanthematous pustulosis due to hydroxychloroquine.
    Castner NB; Harris JC; Motaparthi K
    Dermatol Ther; 2018 Sep; 31(5):e12660. PubMed ID: 30152569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute generalized exanthematous pustulosis induced by empiric hydroxychloroquine for presumed COVID-19.
    Enos T; Jeong HS; Vandergriff T; Jacobe HT; Chong BF
    Dermatol Ther; 2020 Nov; 33(6):e13834. PubMed ID: 32542893
    [No Abstract]   [Full Text] [Related]  

  • 9. Prolonged acute generalized exanthematous pustulosis and atypical target-like lesions induced by hydroxychloroquine.
    Otake-Irie H; Nakajima S; Okamoto N; Toichi E; Nomura T; Kabashima K
    J Dermatol; 2020 Nov; 47(11):e387-e388. PubMed ID: 32770860
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute generalized exanthematous pustulosis induced by hydroxychloroquine successfully treated with etretinate.
    Matsuda-Hirose H; Sho Y; Yamate T; Nakamura Y; Saito K; Takeo N; Nishida H; Ishii K; Sugiura K; Hatano Y
    J Dermatol; 2020 Feb; 47(2):e53-e54. PubMed ID: 31840277
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute generalized exanthematous pustulosis induced by hydroxychloroquine.
    Hsieh CH; Yao CA; Lo Y
    Kaohsiung J Med Sci; 2021 Dec; 37(12):1122-1123. PubMed ID: 34390130
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute generalized exanthematous pustulosis following treatment with favipiravir in a patient with COVID-19 without hydroxychloroquine use: Report of the first case.
    Atak MF; Farabi B; Akbayrak A; Kalelioğlu MB; Rao BK
    J Cosmet Dermatol; 2021 Aug; 20(8):2387-2389. PubMed ID: 34139069
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute generalized exanthematous pustulosis induced by hydroxychloroquine: first case report in Canada and review of the literature.
    Bailey K; McKee D; Wismer J; Shear N
    J Cutan Med Surg; 2013; 17(6):414-8. PubMed ID: 24138979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute generalized exanthematous pustulosis after COVID-19 treatment with hydroxychloroquine.
    Litaiem N; Hajlaoui K; Karray M; Slouma M; Zeglaoui F
    Dermatol Ther; 2020 Jul; 33(4):e13565. PubMed ID: 32401410
    [No Abstract]   [Full Text] [Related]  

  • 15. AGEP sine pustulosis induced by hydroxychloroquine used for COVID-19 infection.
    Demircioğlu D; Karabıyık N; Durmaz EÖ; Demirkesen C; Şahin S
    Dermatol Ther; 2022 Mar; 35(3):e15263. PubMed ID: 34907646
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute generalized exanthematous pustulosis with erythema multiforme-like lesions induced by Hydroxychloroquine in a woman with coronavirus disease 2019 (COVID-19).
    Robustelli Test E; Vezzoli P; Carugno A; Raponi F; Gianatti A; Rongioletti F; Sena P
    J Eur Acad Dermatol Venereol; 2020 Sep; 34(9):e457-e459. PubMed ID: 32386448
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute generalized exanthematous pustulosis due to terbinafine.
    Ross CL; Shevchenko A; Mollanazar NK; Hsu S; Motaparthi K
    Dermatol Ther; 2018 Jul; 31(4):e12617. PubMed ID: 29786933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute generalized exanthematous pustulosis due to hydroxichloroquine.
    Odorici G; Schenetti C; Pacetti L; Schettini N; Gaban A; Mantovani L
    Dermatol Ther; 2022 Jul; 35(7):e15520. PubMed ID: 35434875
    [No Abstract]   [Full Text] [Related]  

  • 19. [Acute generalized exanthematic pustulosis induced by hydroxychloroquine: case report].
    Djennane M; Tablit I; Billhot M; Banal F
    Rev Med Interne; 2010 Mar; 31(3):e7-8. PubMed ID: 20089332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. June 2021: Acute generalized exanthematous pustulosis in Asia.
    Kantor J
    J Am Acad Dermatol; 2021 Jun; 84(6):1544. PubMed ID: 33892969
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.